You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 108 No. 5, May 1990 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  CLINICAL SCIENCES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Recovery of Spatial Vision Following Shunting for Hydrocephalus

Milan E. Tytla, PhD; J. Raymond Buncic, MD

Arch Ophthalmol. 1990;108(5):701-704.


Abstract



• Individuals with papilledema due to intracranial hypertension often exhibit a loss of contrast sensitivity confined to low spatial frequency (coarse detail), which can disappear following treatment of the intracranial hypertension. The basis of the initial loss may be revealed by the rate of sensitivity recovery. We monitored the contrast sensitivity of seven patients immediately before and after surgical treatment in which a shunt was placed for intracranial hypertension. Compared with normal controls, the 13 of 14 eyes with papilledema exhibited the characteristic preshunt loss of sensitivity. For the first 3 days after shunt placement, sensitivity remained approximately equal to preshunt levels. By postshunt days 4 through 6, sensitivity rapidly normalized and remained normal for up to 1 year. Based on the rate and pattern of sensitivity normalization, we conclude that the initial loss represents an interaction of axoplasmic stasis with ischemia at the level of the optic nerve.



Author Affiliations



From the Department of Ophthalmology, The Hospital for Sick Children, Toronto, Canada.


Footnotes



Accepted for publication on October 30, 1989.

Read before the annual meetings of the Association for Research in Vision and Ophthalmology, Sarasota, Fla, May 4, 1989, and the Canadian Ophthalmological Society, Calgary, Canada, June 27, 1989.

Reprints to Department of Ophthalmology, The Hospital for Sick Children, 555 University Ave, Toronto, Ontario, Canada, M5G 1X8 (Dr Tytla).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.